RM, I LIKE YOUR RESILIENCE BUD... But $200 a share is asking too much... Lol... That will need some serious upside and roadmap to a banger performance... I dont know... These bios get promising and FDA or further clinical trials seem to shoot them in the head and the carcass thrown back to the start line... But nevertheless Good luck to holders... Just remember big rises potentially big falls... I sincerely hope I am wrong on this one... IMO GLTAH
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica, page-124
-
- There are more pages in this discussion • 94 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ZLD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
70.0¢ |
Change
-0.005(0.71%) |
Mkt cap ! $7.943M | |||
| Open | High | Low | Value | Volume |
| 73.5¢ | 73.5¢ | 70.0¢ | $1.176K | 1.633K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 67.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 70.0¢ | 1846 | 1 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| ZLD (ASX) Chart |